STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Q
Not yet recruiting
- Malignant Melanoma
- (no location specified)
2021-06-15
Jun 15, 2021C
Terminated
- Melanoma
- Malignant Melanoma
- Immunostimulating Interstitial Laser Thermotherapy
- Stockholm, SwedenKarolinska University Hospital Solna
2021-07-02
Jul 2, 2021Q
Not yet recruiting
- Locally Advanced or Metastatic Acral Malignant Melanoma
- Toripalimab and Anlotinib
- Jinan, Shandong, ChinaQilu Hospital of Shandong University
2021-10-08
Oct 8, 2021O
Recruiting
- Melanoma
- Biospecimen Collection
- Columbus, OhioOhio State University Comprehensive Cancer Center
2021-10-15
Oct 15, 2021C
Recruiting
- Malignant Melanoma
- Angiosarcoma
- CICS-1 (investigational device),SPM-011(investigational drug)
- Chuo Ku, Tokyo, JapanNational Cancer Center Hospital
2021-08-02
Aug 2, 2021W
Recruiting
- Melanoma
- Wuhan, Hubei, ChinaChina, Hubei Province
2022-02-10
Feb 10, 2022U
Active, not recruiting
- Malignant Melanoma
- Ipilimumab
- +2 more
- Oslo, NorwayOslo University Hospital, Radiumhospitalet
2021-05-14
May 14, 2021B
Completed
- Melanoma
- Chiyoda-ku, Tokyo, Japan
- +1 more
2022-02-11
Feb 11, 2022L
Recruiting
- Malignant Melanoma
- delolimogene mupadenorepvec
- atezolizumab
- Los Angeles, California
- +2 more
2022-04-04
Apr 4, 2022F
Recruiting
- Malignant Melanoma
- toripalimab
- Temozolomide Injection
- Hangzhou, Zhejiang, ChinaDepartment of Medical Onocology, First Affiliated Hospital of Zh
2021-05-10
May 10, 2021M
Recruiting
- Fecal Microbiota Transplantation
- +2 more
- Allogenic Fecal Microbiota Transplantation
- Autologous Fecal Microbiota Transplantation
- Graz, AustriaMedical University of Graz
2021-10-11
Oct 11, 2021Y
Not yet recruiting
- SCLC
- +2 more
- GD2-SADA:177Lu-DOTA Complex
- (no location specified)
2022-01-05
Jan 5, 2022D
Not yet recruiting
- Malignant Melanoma
- +4 more
- Pembrolizumab
- +2 more
- (no location specified)
2022-03-31
Mar 31, 2022M
U
Completed
- Melanoma
- +4 more
- therapeutic conventional surgery
- +3 more
- Orange, CaliforniaChao Family Comprehensive Cancer Center
2020-12-30
Dec 30, 2020A
Active, not recruiting
- Unresectable Stage IIIB-IV Malignant Melanoma
- Talimogene laherparepvec
- Nagoya-shi, Aichi, Japan
- +8 more
2021-12-02
Dec 2, 2021M
Completed
- Malignant Melanoma
- Graz, Styria, AustriaMedical University of Graz
2020-11-23
Nov 23, 2020H
Completed
- Malignant Melanoma
- patient with melanoma pre transplantation
- Lyon, Rhone, Franceservice de dermatologie - hopital Edouard Herriot
2021-12-09
Dec 9, 2021N
Completed
- Malignant Melanoma
- Recurrent Melanoma
- Dacarbazine
- +2 more
- (no location specified)
2020-10-18
Oct 18, 2020B
Completed
- Malignant Melanoma Stage III
- Malignant Melanoma Stage IV
- TriMix-DC and ipilimumab
- Jette, Brabant, BelgiumUZ Brussel
2021-03-24
Mar 24, 2021U
Active, not recruiting
- Malignant Melanoma
- Santa Monica, California
- +3 more
2021-05-20
May 20, 2021B
Completed
- Malignant Melanoma
- BMS-936558 (MDX1106-04)
- Ipilimumab
- New Haven, Connecticut
- +3 more
2021-03-19
Mar 19, 2021S
Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma - 2012
Terminated
- Metastatic Malignant Melanoma
- Dendritic cells - transfected with hTERT-, survivin- and tumor cell derived mRNA + ex vivo T cell expansion and reinfusion
- Temozolomide
- Oslo, Montebello, NorwayThe Norwegian Radium Hospital, Department of Clinical Cancer Res
2021-02-23
Feb 23, 2021U
Recruiting
- Cutaneous Malignant Melanoma
- Vitamin D
- arachides oleum raffinatum
- Edegem, Belgium
- +3 more
2020-11-04
Nov 4, 2020F
Recruiting
- Malignant Melanoma
- Camrelizumab for injection
- Shanghai, Shanghai, China
- +1 more
2020-12-20
Dec 20, 2020